(Q39997604)

English

T-cell receptor/CD28 engagement when combined with prostaglandin E2 treatment leads to potent activation of human T-cell leukemia virus type 1.

scientific article

Statements

T-cell receptor/CD28 engagement when combined with prostaglandin E2 treatment leads to potent activation of human T-cell leukemia virus type 1. (English)
1 reference
Nancy Dumais
1 reference
Marie-Eve Paré
1 reference
Simon Mercier
1 reference
Salim Bounou
1 reference
Susan J Marriot
1 reference
Benoit Barbeau
1 reference
Michel J Tremblay
1 reference
1 October 2003
1 reference
77
1 reference
11170-11179
1 reference
20
1 reference

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit